4 Recruiting Stargardt Disease Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for stargardt disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Stargardt Disease studiesPhase 1 / Phase 2 Studies for Stargardt Disease
🟢 Recruiting Phase1 / Phase2
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
📍 RayTx Clinical Site — Bakersfield, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
📍 University of San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
📍 Associated Retina Consultants — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
📍 UCHealth Sue Anschutz-Rodgers Eye Center, — Aurora, Colorado
View Study & Checklist ➔